---
figid: PMC7190945__WJCC-8-1361-g002
figlink: pmc/articles/PMC7190945/figure/F2/
number: F2
caption: 'Effects of VSL#3 on intestinal barrier function. VSL#3 acts on the four
  components of the intestinal barrier: The mechanical barrier, biological barrier,
  chemical barrier, and immune barrier. In terms of the mechanical barrier, VSL#3
  can increase occludin and zonula occludens-1 and decrease claudin-2 in order to
  improve tight junction protein function, and the effect is achieved by increasing
  the activity of T-cell protein tyrosine phosphatase, which is able to decrease T-cell
  protein tyrosine phosphatase-dependent interferon-γ signaling and increase transepithelial
  electrical resistance[-]. VSL#3 can increase transepithelial electrical resistance
  by activating the mitogen-activated protein kinase p42/44 and p38 pathway[]. In
  terms of the biological barrier, VSL#3 can increase the amount of intestinal commensal
  bacteria and decrease the amount of fungi[]. In terms of the chemical barrier, VSL#3
  can increase MUC2, MUC3 and MUC5AC gene expression to regulate mucus secretion[].
  In terms of the immune barrier, VSL#3 can inhibit the proinflammatory nuclear factor-κB
  (NF-κB) pathway, such as inducing heat shock protein (HSP) and reducing monocyte
  chemoattractant protein-1 (MCP-1). The action mechanism is via the early inhibition
  of proteasome by producing soluble factors[]. VSL#3 also up-regulates the peroxisome
  proliferator-activated receptor α (PPARα) signaling pathway to antagonize the NF-κB
  pathway[]. An appropriate dose of VSL#3 can induce the maturation of dendrite cells
  (DC)[,], and VSL#3 can inhibit interferon-inducible protein-10 (IP-10) in intestinal
  epithelial cells (IEC)[-] and the lipopolysaccharide (LPS)-induced expression of
  chemokines (CXCL9, CXCL10, CCL2, CCL7, and CCL8) by inhibiting STAT-1 phosphorylation[].
  VSL#3 is also able to decrease interleukin (IL)-12 (p40) production induced by LPS[].
  Moreover, VSL#3 can induce IL-10 produced by DC and decrease the influx of innate
  immune cells (CD11b+) and adaptive immune cells (CD4+/CD8+)[,]. The down-regulation
  of the signaling pathway of Toll-like receptors (TLR) by VSL#3 also has benefits
  for the intestinal immune barrier[]. IEC: Intestinal epithelial cells; ZO-1: Zonula
  occludens-1; TCPTP: T-cell protein tyrosine phosphatase; IFN-γ: Interferon-γ; TER:
  Transepithelial electrical resistance; MAPK: Mitogen-activated protein kinase; GALT:
  Gut-associated lymphoid tissue; IEL: Intraepithelial lymphocytes; LPL: Lamina propria
  lymphocytes; sIgA: secreted immunoglobulin A; NF-κB: Nuclear factor-κB; IL: Interleukin;
  MCP-1: Monocyte chemoattractant protein-1; HSP: Heat shock protein; PPARα: Peroxisome
  proliferator-activated receptor α; IP-10: Interferon-inducible protein-10; DC: Dendrite
  cells; LPS: Lipopolysaccharide; TLR: Toll-like receptors.'
pmcid: PMC7190945
papertitle: 'Probiotic mixture VSL#3: An overview of basic and clinical studies in
  chronic diseases.'
reftext: Fang-Shu Cheng, et al. World J Clin Cases. 2020 Apr 26;8(8):1361-1384.
pmc_ranked_result_index: '102944'
pathway_score: 0.9548457
filename: WJCC-8-1361-g002.jpg
figtitle: VSL#3 on intestinal barrier function
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7190945__WJCC-8-1361-g002.html
  '@type': Dataset
  description: 'Effects of VSL#3 on intestinal barrier function. VSL#3 acts on the
    four components of the intestinal barrier: The mechanical barrier, biological
    barrier, chemical barrier, and immune barrier. In terms of the mechanical barrier,
    VSL#3 can increase occludin and zonula occludens-1 and decrease claudin-2 in order
    to improve tight junction protein function, and the effect is achieved by increasing
    the activity of T-cell protein tyrosine phosphatase, which is able to decrease
    T-cell protein tyrosine phosphatase-dependent interferon-γ signaling and increase
    transepithelial electrical resistance[-]. VSL#3 can increase transepithelial electrical
    resistance by activating the mitogen-activated protein kinase p42/44 and p38 pathway[].
    In terms of the biological barrier, VSL#3 can increase the amount of intestinal
    commensal bacteria and decrease the amount of fungi[]. In terms of the chemical
    barrier, VSL#3 can increase MUC2, MUC3 and MUC5AC gene expression to regulate
    mucus secretion[]. In terms of the immune barrier, VSL#3 can inhibit the proinflammatory
    nuclear factor-κB (NF-κB) pathway, such as inducing heat shock protein (HSP) and
    reducing monocyte chemoattractant protein-1 (MCP-1). The action mechanism is via
    the early inhibition of proteasome by producing soluble factors[]. VSL#3 also
    up-regulates the peroxisome proliferator-activated receptor α (PPARα) signaling
    pathway to antagonize the NF-κB pathway[]. An appropriate dose of VSL#3 can induce
    the maturation of dendrite cells (DC)[,], and VSL#3 can inhibit interferon-inducible
    protein-10 (IP-10) in intestinal epithelial cells (IEC)[-] and the lipopolysaccharide
    (LPS)-induced expression of chemokines (CXCL9, CXCL10, CCL2, CCL7, and CCL8) by
    inhibiting STAT-1 phosphorylation[]. VSL#3 is also able to decrease interleukin
    (IL)-12 (p40) production induced by LPS[]. Moreover, VSL#3 can induce IL-10 produced
    by DC and decrease the influx of innate immune cells (CD11b+) and adaptive immune
    cells (CD4+/CD8+)[,]. The down-regulation of the signaling pathway of Toll-like
    receptors (TLR) by VSL#3 also has benefits for the intestinal immune barrier[].
    IEC: Intestinal epithelial cells; ZO-1: Zonula occludens-1; TCPTP: T-cell protein
    tyrosine phosphatase; IFN-γ: Interferon-γ; TER: Transepithelial electrical resistance;
    MAPK: Mitogen-activated protein kinase; GALT: Gut-associated lymphoid tissue;
    IEL: Intraepithelial lymphocytes; LPL: Lamina propria lymphocytes; sIgA: secreted
    immunoglobulin A; NF-κB: Nuclear factor-κB; IL: Interleukin; MCP-1: Monocyte chemoattractant
    protein-1; HSP: Heat shock protein; PPARα: Peroxisome proliferator-activated receptor
    α; IP-10: Interferon-inducible protein-10; DC: Dendrite cells; LPS: Lipopolysaccharide;
    TLR: Toll-like receptors.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP14
  - PTPN2
  - ITGAM
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - TECR
  - CCR8
  - CD4
  - CXCL10
  - TJP1
  - CCL16
  - GALT
  - LPL
  - TLR1
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR8
  - TLR9
  - TLR2
  - TLR7
  - TLR10
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - CD8A
  - CD8B
  - IRF6
  - PPARA
  - PPARG
  - PPARD
  - IL12A
  - IL12B
  - STAT1
genes:
- word: mice
  symbol: MICE
  source: hgnc_alias_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: ТСРТР
  symbol: TCPTP
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN2
  entrez: '5771'
- word: CD11b'
  symbol: CD11B
  source: hgnc_prev_symbol
  hgnc_symbol: ITGAM
  entrez: '3684'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: TER
  symbol: TER
  source: hgnc_alias_symbol
  hgnc_symbol: TECR
  entrez: '9524'
- word: TER1
  symbol: TER1
  source: hgnc_alias_symbol
  hgnc_symbol: CCR8
  entrez: '1237'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: CD4
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: IP-10
  symbol: IP-10
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: zo-1
  symbol: ZO-1
  source: hgnc_alias_symbol
  hgnc_symbol: TJP1
  entrez: '7082'
- word: IEC
  symbol: LEC
  source: hgnc_alias_symbol
  hgnc_symbol: CCL16
  entrez: '6360'
- word: GALT
  symbol: GALT
  source: hgnc_symbol
  hgnc_symbol: GALT
  entrez: '2592'
- word: LPL
  symbol: LPL
  source: hgnc_symbol
  hgnc_symbol: LPL
  entrez: '4023'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR!
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: CD4*
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: -LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARG
  entrez: '5468'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARD
  entrez: '5467'
- word: CD4'/CD8*i
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: CD4'/CD8*
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: STAT-1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
chemicals: []
diseases: []
figid_alias: PMC7190945__F2
redirect_from: /figures/PMC7190945__F2
figtype: Figure
---
